Related Experiment Video
Updated: Oct 4, 2025

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Analgosedation before Less-Invasive Surfactant Administration: A Systematic Review.
Sophie Tribolet1, Nadège Hennuy1, Diane Snyers1
1Neonatology Division, University Hospital of Liège, Liège, Belgium.
Analgosedation during less-invasive surfactant administration (LISA) improves infant comfort and procedural conditions. While it increases transient respiratory events, it does not impact long-term outcomes, suggesting a favorable risk-benefit profile for this neonatal respiratory distress syndrome management technique.
Area of Science:
- Neonatalogy
- Pediatric Critical Care
- Pharmacology
Background:
- Less-invasive surfactant administration (LISA) is recommended for preterm infants with respiratory distress syndrome.
- Analgosedation use during LISA is inconsistent among neonatologists.
- This review evaluates the efficacy and safety of analgosedation for LISA.
Approach:
- Systematic review of studies on sedation/analgesia for LISA.
- Searched MEDLINE, Embase, Scopus, and Cochrane Library.
- Included 8 studies (1 RCT) with 945 infants.
Key Points:
- Analgosedation significantly reduced infant pain and improved comfort.
- Procedural success was high (83% good/excellent) with analgosedation.
- No difference in treatment failure (intubation, repeat surfactant) or 24/72h mechanical ventilation.
- Increased desaturation and need for positive pressure ventilation during procedure.
- No significant difference in clinical tolerance or complications (hypotension, mortality, air leaks).
Conclusions:
- Analgosedation enhances infant comfort and procedural conditions during LISA.
- Limited impact on clinical evolution, but optimal drug choice and dosage require further study.
- Need for spontaneous breathing and rapid drug offset are key considerations for future research.
More Related Videos
Related Concept Videos
Breathing
Skeletal Muscle Relaxants: Therapeutic Uses
Inhalational Anesthetics: Overview
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
Skeletal Muscle Relaxants: Adverse Effects
Unlike...

